We Venture Capital
Investor profile
Venture capital
We Venture Capital has backed 4 European tech companies across 4 funding rounds between 2024 and 2025, joining rounds totalling €92M. Most active in Healthtech and Software. Data as of 4 Nov 2026.
Deals
4
distinct rounds
Companies
4
backed
Active span
2024–2025
2 yrs
Total round €
€92M
sum of rounds joined
Deals by year
distinct rounds / yearWe Venture Capital — deals by year — interactive chart.
Data table
| We Venture Capital — deals by year | |
|---|---|
| 2024 | 1 |
| 2025 | 3 |
Top sectors
by dealsWe Venture Capital — top sectors — interactive chart.
Data table
| We Venture Capital — top sectors | |
|---|---|
| Healthtech | 3 |
| Software | 1 |
Stages
by dealsWe Venture Capital — stages — interactive chart.
Data table
| We Venture Capital — stages | |
|---|---|
| Series A | 2 |
| Seed | 1 |
| Series C | 1 |
Countries
by dealsWe Venture Capital — countries — interactive chart.
Data table
| We Venture Capital — countries | |
|---|---|
| UK | 3 |
| Spain | 1 |
Co-investment network
shared roundsCo-investment network — interactive chart.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
Frequent co-investors
shared rounds- 8VC1
- Aliath Bioventures1
- Amino Collective1
- Asabys Partners1
- Aurelium Ventures1
- Axis-Ico1
- British Business Bank1
- CGHealth Ventures1
- Civilization Ventures1
- Columbus Venture Partners1
- Cross Border Impact Ventures1
- DigitalDx Ventures1
- Earlybird Venture Capital1
- Eka Ventures1
- Gesamo1
- Innvierte-CDTI1
- Macmillan Cancer Support1
- Mérieux Equity Partners1
- NATO Innovation Fund1
- OKG Capital1
- Outsized Ventures1
- Panakès Partners1
- Pillar VC1
- SCVC1
- WS Investment Company1
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Deepull | Spain | 1 | €50M |
| Portal Biotech | UK | 1 | €30M |
| Oxcan | UK | 1 | €11M |
| Zetta Genomics | UK | 1 | €2.1M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Deepull | Series C | €50M | 2025-04 |
| Portal Biotech | Series A | €30M | 2025-07 |
| Oxcan | Series A | €11M | 2025-01 |
| Zetta Genomics | Seed | €2.1M | 2024-02 |